TB Eradication Expenditure
Angela Robinson
Assistant Principal Officer
ERAD Division
TB Conference
Carlton Hotel
9 –10 October 2007
TB Programme – Expenditure
Overview
How much does the TB Eradication
Programme cost?
How is the TB programme financed?
Main expenditure items, including
compensation
TB Programme - Gross
expenditure (not incl. admin costs)
1999
2000
2001
2002
2003
2004
2005
2006
€m
49.5
45.5
34.7
40.7
40.1
36.3
39.6
38.3
TB Programme – Gross
Expenditure
55
Millions
50
45
40
35
30
25
1999
2000
2001
2002
2003
Gross Expenditure
2004
2005
2006
TB Programme expenditure –
sources of funding
National Exchequer
Farmer levies
Estimated €13.9m in 1996
 Estimated €10.4m in 2006
 Further reduction in 2007

EU contribution
TB Programme – main
expenditure items
Vet fees for herd testing
Reactor collection service
Supplies – purchase of tuberculin, kits
Wildlife programme
Research
Compensation
DAFF administrative costs
Main expend items Vet fees – herd testing
Pre 1996 all testing was paid by DAF
Post 1996 to date farmer pays for one
test per year except where reactors are
disclosed
Total spend on vet fees in 2006 was
€8.59m
Main expend items
Reactor collection service
Reactor collection from farm direct to
slaughter plant
Objective: rapid removal minimises risk
of spread of disease
Hauliers engaged following tender
invitation
Cost of RCS in 2006 was €0.8m
Main expend items Supplies
Supplies including tuberculin (€4m),
supply of kits, lab equipment supplies
Total spend on supplies in 2006 was
€5m
Main expend items –
Wildlife programme
2000 Partnership Agreement
Committed to enhancing wildlife
strategy
Funding increased from €1m in 2000 to
€2.6m in 2006
Main expend items –
Research
Funding provided for:




Centre for Veterinary Epidemiology and Risk
Analysis (CVERA)
The TB Diagnostics and Immunology Research
Centre
The Badger Vaccine project
Various post-graduate studies
Policy advice and epid. and scientific
research
Total spend on research 2000 was €1.1m
and in 2006 was €2m
Main expend items Compensation Schemes
On Farm Market Valuation Payment
Income Supplement
Depopulation Grant
Hardship Grant
Penalties up to 100% where there are
breaches of terms and conditions,
legislation and/or disease control
requirements
On Farm Market Valuation
- main terms
Replaced reactor grant (flat rate)
Fully rolled out in 2002
Market value – in line with EU Task Force
recommendation - subject to ceilings


€2,800 (inclusive of factory salvage price) per
individual animal
€3,500 for one pedigree stock bull per breakdown
episode
On-Farm Market Valuation main terms contd.
Independent valuation
Guideline market prices compiled weekly
from selected marts issued to valuers
Salvage value paid by factory to farmer
DAFF pays difference between salvage value
and market value
DAFF pays full costs of 1st valuation
Appeal and arbitration mechanisms
Depopulation – main terms
Objective: to compensate farmers for
loss of income arising from
depopulation
Herdowner must agree to depopulation
at the time specified by the Department
Payable for animals removed where full
or partial depopulation is considered
appropriate
Income Supplement – main
terms
Objective: to compensate farmers for loss of
income arising from removal of animals
Payable where removal is > than 10% of
animals
Depopulation not considered appropriate
Maximum: first 100 animals only
Hardship Grant – main terms
Assists farmers with additional feed costs
where animals are retained/fed during
periods of restriction
Eligibility period between 1 November and 30
April
Following reactor re-test


No off-farm income
No income from milk sales
Maximum €250.00 per month for a period not
exceeding 4 months during eligibility period
Conclusion - Objective of
DAFF financial intervention
Compensation
 removal of privately owned assets
 loss of income arising from restriction of
movements
 Minimises risk of failure to disclose disease
Payment for herd testing supports regulatory
framework of the testing regime to progress
eradication
Rapid removal of reactors minimises risk of further
spread of disease
Research to underpin eradication/wildlife policy,
including in particular, the development of vaccine